Bone is the most common site of metastasis for breast cancer. Bone metastasis significantly
affects both quality of life and survival of the breast cancer patient. Clinically, complications …

Summary The SPine response assessment In Neuro-Oncology (SPINO) group is a
committee of the Response Assessment in Neuro-Oncology working group and comprises a …

We are in the midst of a technological revolution that is providing new insights into human
biology and cancer. In this era of big data, we are amassing large amounts of information …

Identifying novel circulating biomarkers predictive of response and informative about the
mechanisms of resistance, is the new challenge for breast cancer (BC) management. The …

Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

Bone metastases are common in patients with advanced breast cancer. Given the significant
associated morbidity, the introduction of new, effective systemic therapies, and the …

Background: We retrospectively evaluated the correlation between a baseline measurement
of circulating tumor cells (CTCs) and inflammation-based scores in patients with metastatic …

Current methods of assessing tumor response at skeletal sites with metastatic disease use a
combination of imaging tests, serum and urine biochemical markers, and symptoms …

Adaptive and innate immune cells play a crucial role as regulators of cancer development.
Inflammatory cells in blood flow seem to be involved in pro-tumor activities and contribute to …

Objective: We investigated the role of 18F-fluorocholine positron emission
tomography/computed tomography (FCH-PET/CT) in the early evaluation of abiraterone and …